Literature DB >> 32567207

Mental health assessment of frontline COVID-19 dermatologists: A Pan-Indian multicentric cross-sectional study.

Abheek Sil1, Anupam Das2, Saurabh Jaiswal3, Mohammad Jafferany4, Akhilesh Thole5, Rahul Rajeev6, Syed Naiyer Ali2.   

Abstract

Entities:  

Year:  2020        PMID: 32567207      PMCID: PMC7361073          DOI: 10.1111/dth.13884

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


× No keyword cloud information.
Dear Editor, Following the outbreak of COVID‐19 pandemic, health care workers are involved in screening, investigations, admission, ward rounds, and even performing life‐resuscitating procedures. Dermatology residents, young faculties, and consultants are not used to handling long hours of duty and stressful environment. We evaluated the mental health status of front‐line dermatologists combating the pandemic. This was a cross‐sectional, observational study. Dermatologists engaged in direct patient contact through clinical services at out‐patient department, designated COVID wards, and fever clinics were included. Those involved in administrative duties and other departmental engagements were excluded. An online semistructured questionnaire was prepared on Google‐forms platform and the link was circulated among the dermatologists (postgraduate trainees, senior residents, and consultants) through emails and social media (snowball sampling). It started from 13 May 2020 9 am and closed on 20 May 2020 at 9 am. The questionnaire, restricted to a single response from each participant, comprised of three sections: first section consisted of demographic details (age, gender, qualification, working hours, current residence, and place of posting). Second section consisted of Patient Health Questionnaire (PHQ‐9) for depression and third section comprised of Perceived Stress Scale. Continuous variables were analyzed using unpaired t test and categorical data by chi‐square test. Statistical software Medcalc version 10.2.0.0 for Windows vista was used. Out of 49 responses received, 8 were excluded, based on exclusion criteria. The demographics of study participants skewed toward a slight male distribution (58.5%). The other details are described in Table 1.
TABLE 1

Study parameters and their relation to depression and stress

Parameters (frequency; n = 41)Depression (n = 11)Stress (n = 12)
Age (years) P = .03* P = .865
<26 (2)01
26‐30 (30)48
>30 (9)73
Sex P = .02* P = .306
Male (24)25
Female (17)97
Designation P = .05 P = .605
Postgraduate trainees (21)108
Senior residents (12)02
Consultants (8)12
Work hours (in hours) P = .821 P = .620
<6 (8)32
6‐12 (30)78
>12 (3)12
Work postings P = .899 P = .229
Out‐patient department (13)33
Fever clinic (23)75
Designated COVID wards (5)14
Currently staying P = .03* P = .776
With family (19)15
Without family (22)107

Means statistically significant.

Study parameters and their relation to depression and stress Means statistically significant. Eleven (26.82%) doctors were depressed, among which six (54.4%) participants were suffering from mild depression. Moderate, moderately severe, and severe depression were encountered in two (18.2%), two (18.2%), and one (9.1%) informants, respectively. Mean depression score was found to be 5.24 ± 3.02. Among the participants with moderate to severe depression, significant association (P < .05) was found with females (P = .02), age >30 years (P = .03), and those staying away from family (P = .03). Out of the total 41 study participants, stress was depicted in 12 (29.2%) doctors, of which stress levels were moderate in 11 (91.7%) and severe in 1 (8.3%) of participants. Mean perceived stress score was found to be 16.38 ± 7.93. Higher perceived stress scores were seen in females, long working hours, working in COVID‐positive wards, and participants staying away from family; however, these were not found to be statistically significant. Our results revealed a 26.82% and 29.2% prevalence of symptoms of depression and stress, respectively, among frontline COVID‐19 dermatologists. A multicenter survey involving 1563 Chinese medical staff revealed depression in 50.7% and 73.4% developed stress related symptoms respectively. Results of a recently published study from Wuhan suggested half of the 1257 health workers reporting symptoms of depression. In an Indian study involving 152 doctors, 34.9% were found to be depressed and 32.9% were experiencing stress. Another recent Indian study concluded that dermatologists too developed high stress, with significant association with females and unmarried individuals, due to the current situation (during home‐quarantine and COVID‐19 pandemic), that was found to be comparable to non‐dermatologists. Our study, in contrast, was restricted to “front‐line” dermatologists only. Akin to our findings, Lai et al showed that being a woman and possessing an intermediate professional title was associated with higher anxiety, depression, and distress. Liang et al reported that medical staff at younger age (<30 years) had higher self‐rated depression scores (statistically insignificant) than those with older age (≥30 years). Older staff can suffer from increased stress and depressive symptoms due to exhaustion from prolonged work hours, concerns for their families, and personal safety. , Being a web‐based survey, the receipt of unsolicited responses could not be accounted for. A larger response rate would have added more credibility. We could have drawn a more convincing conclusion if we had compared the study population with nondermatologists, who are more frequently posted in COVID isolation wards and intensive care units. Health care authorities should allocate resources (adequate screening, psychological counseling, or self‐help interventions including cognitive behavior therapy) to ensure the mental well‐being of the healers. To the best of our knowledge, this is the first of its kind assessment of the psychological status of front‐line dermatologists amidst this tough time.

DISCLAIMER

We confirm that the manuscript has been read and approved by all the authors, that the requirements for authorship as stated earlier in this document have been met and that each author believes that the manuscript represents honest work.
  6 in total

Review 1.  Mental health research in the lower-middle-income countries of Africa and Asia during the COVID-19 pandemic: A scoping review.

Authors:  Sujita Kumar Kar; Tosin Philip Oyetunji; Aathira J Prakash; Olusegun Ayomikun Ogunmola; Sarvodaya Tripathy; Monsurat M Lawal; Zainab K Sanusi; S M Yasir Arafat
Journal:  Neurol Psychiatry Brain Res       Date:  2020-10-28

Review 2.  Experiences and management of physician psychological symptoms during infectious disease outbreaks: a rapid review.

Authors:  Kirsten M Fiest; Jeanna Parsons Leigh; Karla D Krewulak; Kara M Plotnikoff; Laryssa G Kemp; Joshua Ng-Kamstra; Henry T Stelfox
Journal:  BMC Psychiatry       Date:  2021-02-10       Impact factor: 3.630

Review 3.  Prevalence of anxiety and depression in South Asia during COVID-19: A systematic review and meta-analysis.

Authors:  Md Mahbub Hossain; Mariya Rahman; Nusrat Fahmida Trisha; Samia Tasnim; Tasmiah Nuzhath; Nishat Tasnim Hasan; Heather Clark; Arindam Das; E Lisako J McKyer; Helal Uddin Ahmed; Ping Ma
Journal:  Heliyon       Date:  2021-04-05

Review 4.  Depression and anxiety associated with COVID- 19 pandemic among healthcare professionals in India- A systematic review and meta-analysis.

Authors:  E K Abdulla; Saleena Ummer Velladath; Aneena Varghese; M Anju
Journal:  Clin Epidemiol Glob Health       Date:  2021-11-04

5.  An Observational Survey to Appraise the Influence of COVID-19 Pandemic on Dermatology Training Programs in India: Residents' Standpoint.

Authors:  Anupam Das; Abheek Sil; Aditi Chakrabarti
Journal:  Indian Dermatol Online J       Date:  2021-05-12

6.  Mental distress in dermatologists during COVID-19 pandemic: Assessment and risk factors in a global, cross-sectional study.

Authors:  Shashank Bhargava; Rashmi Sarkar; George Kroumpouzos
Journal:  Dermatol Ther       Date:  2020-09-03       Impact factor: 3.858

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.